References
- Ohlsson B, Veréss B, Janciauskiene S, Montgomery A, Haglund M, Wallmark A. Chronic intestinal pseudo-obstruction due to induced formation of anti-GnRH antibodies destroying GnRH-producing neurons of the myenteric plexus. Gastroenterology 2007; 132: 45–51
- Elbert EC. Esophageal disease in scleroderma. J Clin Gastroenterol 2006; 40: 769–75
- Vitali C. Classification criteria for Sjögren's syndrome. Ann Rheum Dis 2003; 62: 94–5
- Mandl T, Granberg V, Apelqvist J, Wollmer P, Manthorpe R, Jacobsson L. Assessment of autonomic symptoms in diabetics. The Swedish version of the Autonomic Symptom Profile (ASP). Clin Physiol Funct Imaging 2008; 28: 312–17
- Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480–91
- Masi AT, Rodnan GP, Medsger TA, Altman RD, D'Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90
- Agréus L, Talley NJ. Dyspepsia: current understanding and management. Annu Rev Med 1998; 49: 475–93
- Gwee KA. Irritable bowel syndrome in developing countries – a disorder of civilization or colonization?. Neurogastroenterol Motil 2005; 17: 317–24
- Maury CPJ, Tornroth T, Teppo AM. Atrophic gastritis in Sjögren's syndrome. Morphologic, biochemical and immunologic findings. Arthritis Rheum 1985; 28: 388–94
- Sheik SH, Shaw-Stiffel TA. The gastrointestinal manifestations of Sjögren's syndrome. Am J Gastroenterol 1995; 90: 9–14